Clinical Assessment of a Daily Wear Monthly Replacement Silicone Hydrogel Toric Contact Lens
1 other identifier
interventional
76
1 country
7
Brief Summary
The purpose of this clinical study is to assess the clinical performance of an investigational toric soft contact lens compared to a commercially available toric contact lens in a crossover dispense trial when worn in a daily wear modality for 30 days, each study lens type.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2022
Shorter than P25 for not_applicable
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 14, 2022
CompletedFirst Posted
Study publicly available on registry
January 27, 2022
CompletedStudy Start
First participant enrolled
February 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 23, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 23, 2022
CompletedResults Posted
Study results publicly available
June 27, 2023
CompletedJune 27, 2023
June 1, 2023
4 months
January 14, 2022
June 5, 2023
June 26, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Distance Visual Acuity (VA) With Study Lenses
Visual acuity (VA) was collected for each eye individually with study lenses in place using a letter chart. VA was measured in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity. No inferences were pre-specified for the primary effectiveness endpoint; therefore, no hypothesis testing was performed.
Day 1 and Day 30, each wear period (approximately 30 days)
Study Arms (2)
LID205255 Toric, then Biofinity Toric
OTHERLehfilcon A toric contact lenses worn first, with comfilcon A toric contact lenses worn second, as randomized. Each product will be worn bilaterally (in both eyes) during waking hours for at least 5 days per week, with up to 10-12 hours wear time per day over a 30-day period. CLEAR CARE will be used for nightly contact lens cleaning and disinfection.
Biofinity Toric, then LID205255 Toric
OTHERComfilcon A toric contact lenses worn first, with lehfilcon A toric contact lenses worn second, as randomized. Each product will be worn bilaterally (in both eyes) during waking hours for at least 5 days per week, with up to 10-12 hours wear time per day over a 30-day period. CLEAR CARE will be used for nightly contact lens cleaning and disinfection.
Interventions
FDA-cleared silicone hydrogel toric contact lenses used as indicated
Commercially available silicone hydrogel toric contact lenses used as indicated
Hydrogen peroxide-based contact lens cleaning and disinfecting solution
Eligibility Criteria
You may qualify if:
- Successful wearers of weekly/monthly toric soft contact lenses in both eyes for a minimum of 5 days per week and 10 hours per day during the past 3 months;
- Best corrected distance visual acuity (as determined by manifest refraction at screening) better than or equal to 20/25 Snellen in each eye.
- Able to wear contact lenses within the range of available sphere \& cylinder power and axes.
You may not qualify if:
- Daily disposable contact lens wearers.
- Monovision and multifocal contact lens wearers.
- Habitual Biofinity Toric/Biofinity Toric XR contact lens wearers in the past 3 months prior to consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Alcon Researchlead
Study Sites (7)
Sabal Eye Care
Longwood, Florida, 32779, United States
Drs. Giedd, P.A.
Maitland, Florida, 32751, United States
Vision Health Institute
Orlando, Florida, 32803, United States
Kannarr Eye Care LLC
Pittsburg, Kansas, 66762, United States
Fischer Laser Eye Center
Willmar, Minnesota, 56201, United States
SUNY College of Optometry Clinical Vision Research Center
New York, New York, 10036, United States
West Bay Eye Associates
Warwick, Rhode Island, 02888, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Clinical Project Lead, CRD Vision Care
- Organization
- Alcon Research, LLC
Study Officials
- STUDY DIRECTOR
Clinical Trial Lead, CRD Vision Care
Alcon Research, LLC
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 14, 2022
First Posted
January 27, 2022
Study Start
February 15, 2022
Primary Completion
June 23, 2022
Study Completion
June 23, 2022
Last Updated
June 27, 2023
Results First Posted
June 27, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share